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Volume 59, Number 6S Abstracts 103SObjectives: The effects of failed lower extremity an-
gioplasty are not well known, and the sequelae of failed
tibial angioplasty have not been reported.
Methods: From 2004 to 2013, 519 patients under-
went a tibial endovascular intervention for critical limb
ischemia. Data collected included clinical outcomes, subse-
quent procedures, and bypass target site before and after
endovascular intervention. Patients without an initial
bypass target were excluded. Those with early failured
deﬁned as restenosis (>3.5 step-up by duplex), revascu-
larization (eg, ipsilateral infrainguinal bypass, percuta-
neous transluminal angioplasty with or without
stenting) or major amputation #6 monthsdwere moni-
tored for negative alterations in initial bypass target (eg,
from tibial to pedal, one tibial to second tibial with worse
outﬂow, or to no further bypass target). Worsened Ruth-
erford class between index procedure and failure was also
noted.
Results: Of the 519 patients, 353 were available for
follow-up >6 months. Early failure occurred in 171 limbs
(48%) in 152 patients. Twelve (7.0%) early failure patients
presented with a worse ischemia class compared with
their initial symptoms, whereas the distal bypass target
was undesirably altered in 14 limbs (8.2%): 4 to altered
tibial targets with worse runoff, 2 from tibial to pedal,
and 8 from an initial target to no bypass target. After early
failure, 101 patients (59%) underwent no further treat-
ment, 57 (33%) underwent repeat angioplasty, and 13
(7.6%) underwent infrainguinal bypass. Limb salvage
was worse among patients without reintervention after
early failure (79% vs 60%; P < .01). Of the 14 patients
experiencing negative bypass target alterations, 1 (7.1%)
had TASC A disease, 4 (28%) TASC C, and 9 (64%)
TASC D.
Conclusions: Tibial angioplasty failure #6 months is
common and alters the distal target in w8% of patients.
These results lend further support to the practice of bypass
as the preferred initial treatment option for TASC D
disease.
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Wlﬂ Stage N (%) Age
Initial
Hospitalization
(median days) DM ESRD
Overall* 63 67+/-13 10 70% 27%
Unstayed1 10 (16%) 64+/-8 10.5 100% 40%
1 9 (14%) 63+/-8 9 56% 33%
2 7 (11%) 64+/-17 11 29% 0%
3 16 (25%) 72+/-16 3 63% 31%
4 17 (27%) 68+/-10 13 88% 29%
5 4 (6%) 71+/-15 10.5 50% 0%
P-Value .38 .22 .07 .33
*Ischemia score not determinedRR21.
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Objectives: The Society for Vascular Surgery (SVS)
Lower Extremity Threatened Limb Classiﬁcation System
was designed for analysis of limb outcomes based on three
factors: wound, ischemia, and foot infection (WIfI). We
sought to assess the utility of WIfI staging in predicting
early outcomes of in-patient limb salvage treatment in a
dedicated amputation prevention program.
Methods: Prospective, single-center analysis was con-
ducted of consecutive patients admitted for treatment of
limb-threatening conditions to a combined vascular/podi-
atry service.
Results: Over a 4-month period, 63 threatened limbs
in 50 patients (32% female; mean age 68) were stratiﬁed
by WIfI stage (1, 14%; 2, 11%; 3, 25%; 4, 27%; 5, 6%;
unstaged, 16%) and followed up beyond hospital discharge
(follow-up range, 2 weeks-4 months). Overall, 70% of limbs
were Rutherford 5; diabetes prevalence was associated with
WIfI stage (Table). Ninety-four percent underwent a revas-
cularization procedure, of which 38% were open bypass. Me-
dian length of stay was 10 days, with an overall 30-day
readmission rate of 27%, which was highest in stage 4
(47%, P ¼ .06). No limbs in stages 1 or 2 required amputa-
tion; both minor and major amputation rates increased in
stage 3 (19% and 6%) and stage 4 (59% and 24%; P ¼ .01;
respectively). None of the 24 limbs treated by open bypass
in this series underwent a major amputation (P ¼ .01).
Wound score (P ¼ .03), hindfoot location (P ¼ .03), and
infection score (P ¼ .01) were associated with major ampu-
tation; baseline comorbidities and ischemia score were not.
Conclusions: Prospective classiﬁcation of threatened
limbs using the SVS WIfI system stratiﬁed patients by
risk for amputation and readmission. In a setting of aggres-
sive revascularization and podiatric care, baseline wound
and infection severity are the dominant factors associated
with early major amputation events.
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Read
mission
Major/Minor
Amputation Rate
Revascularizations
(Bypass%)
68% 27% 14%/25% 94% (38%)
60% 0% 0%/30% 100% (30%)
66% 22% 0%/0% 66% (22%)
100% 0% 0%/0% 100% (71%)
69% 38% 6.3%/19% 93.8% (38%)
77% 47% 23.5%/59% 100% (47%)
0% 25% 100%/N/A 0%
.02 .06 .01/.01 .18
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Objectives: The purpose of this study is to compare
the effectiveness of peripheral vascular intervention (PVI)
vs surgical bypass grafts (BPG) for critical limb ischemia
(CLI) in the Vascular Study Group of Greater New York
(VSGGNY).
Methods: Patients undergoing BPG or PVI for CLI at
VSGGNY centers (2011-2013) were included. Using the
Society for Vascular Surgery Objective Performance Goals
(OPGs) for CLI, the safety and effectiveness of PVI and
BPG were initially directly compared. Propensity score
(PS) matching enabled risk-adjusted comparisons of PVI
vs BPG.
Results: A total of 414 patients (268 PVI, 146 BPG)
were treated for tissue loss (69%) or rest pain (31%). Pa-
tients undergoing PVI were more likely to have tissue
loss (74.6% vs 57.5%; P < .001) and comorbidities,
including diabetes (69.3% vs 57.5%; P ¼ .02), heart fail-
ure (22% vs 13.7%; P ¼ .04), and severe renal disease
(13.1% vs 4.1%; P ¼ .004). There were no signiﬁcant dif-
ferences across a panel of safety OPGs. At 1 year, direct
comparison of cohorts suggested superior effectiveness
with BPG: freedom from reintervention, amputation, or
restenosis (90.4% vs 81.7%; P ¼ .02) and freedom from
reintervention or amputation (92.5% vs 85.8%, P ¼
.045). After PS matching, PVI was associated with
increased freedom from major adverse limb events and
postoperative death at 1 year (95.6% vs 88.5%; P < .05;
Table).
Conclusions: By unadjusted comparison, early rein-
tervention and restenosis are more prevalent with PVI.
However, risk-adjusted comparison underscores the safety
and effectiveness of PVI in the treatment of CLI.Table. Vascular Study Group of Greater New York (VSGGNY
Outcome Metric
Unmatched coh
PVI BPG
(n ¼ 268) (n ¼ 14
% (CI) % (CI)
Amputationa 97.0 (95.0-99.1) 97.9 (95
Reintervention, amputation, or restenosisa 81.7 (77.1-86.3) 90.4 (85
Reintervention or amputationa 85.8 (81.6-90.0) 92.5 (88
Major adverse limb events + post-op deatha 89.6 (85.9-93.2) 90.4 (85
Amputation-free survival 87.7 (83.8-91.6) 91.1 (86
Overall survival 90.3 (86.8-93/8) 93.2 (89
a Reported as freedom from event.Author Disclosures: P. H. Connolly: Nothing to
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Objectives: Medicare’s Hospital Readmissions Reduc-
tion Program (HRRP) will require public reporting of
postsurgical readmission rates and ﬁnancial penalties for
high readmitting hospitals. Concerned with creating a dou-
ble standard for hospitals treating a high percentage of
indigent patients, Medicare elected to exclude socioeco-
nomic status (SES) from its risk-adjustment model. How-
ever, recent evidence suggests that hospitals caring for a
disproportionate share of low SES patients are more likely
to be penalized for excess readmissions. We sought to
investigate the effect of including SES on penalties and
reporting of hospital readmission rates following lower ex-
tremity revascularization procedures.
Methods: We used national Medicare data on 507,256
patients undergoing lower extremity arterial bypass, angio-
plasty, or stent placement between 2005 and 2009 to
generate risk-standardized 30-day readmission rates (RSRR).
We included only hospitals treating all strata of SES. Our
initial logistic regression model included age, sex, comorbid-
ities, and procedure type. We created a second model that
added SES as a three-level variable (low, medium, high).
Next, we tested whether including SES changed the propor-
tion of hospitals penalized under the HRRP, or penalty size.
Results: Our study population comprised 1909 hospi-
tals with an overall RSRR of 14.0% 6 1.6%. There was no
difference in the proportion of hospitals penalized after
adjusting for SES (56.5% vs 56.4%, P ¼ .885). However,
58% of institutions would receive lower penalties. Further,
hospitals treating a greater proportion of low-SES patients
more commonly received reduced penalties after adjustment
(odds ratio, 3.33; 95% conﬁdence interval, 2.42-4.60).) 12-month unadjusted and adjusted outcomes
orts Propensity-matched cohorts
P
PVI BPG
P
6) (n ¼ 113) (n ¼ 113)
% (CI) % (CI)
.6-100.0) .574 99.1 (95.2-100.0) 98.2 (93.8-99.8) .561
.6-95.2) .019 84.1 (76-90.3) 89.4 (82.2-94.4) .239
.2-96.7) .045 88.5 (81.1-93.7) 91.2 (84.3-95.7) .509
.6-95.2) .782 95.6 (90.0-98.5) 88.5 (81.1-93.7) .049
.5-95.7) .292 95.6 (90.0-98.5) 90.3 (83.2-95.0) .120
.1-97.2) .325 96.5 (91.2-99.0) 92.0 (85.4-96.3) .153
